QCRH(QCRH)
QCRH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $425M | $450M |
| Low | $421M | $446M |
| High | $429M | $453M |
| EBITDA Avg | $129M | $136M |
| Low | $127M | $135M |
| High | $130M | $137M |
| EBIT Avg | $119M | $126M |
| Low | $118M | $125M |
| High | $120M | $127M |
| Net Income Avg | $137M | $147M |
| Low | $135M | $143M |
| High | $139M | $150M |
| EPS Avg | $8.16 | $8.69 |
| Low | $8.06 | $8.56 |
| High | $8.27 | $8.96 |
| Analysts (Rev / EPS) | 2 / 4 | 2 / 4 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $104M | $109M | $113M | $105M | $111M | $115M | $119M |
| Low | $103M | $107M | $111M | $103M | $109M | $114M | $117M |
| High | $105M | $111M | $114M | $106M | $112M | $117M | $120M |
| EBITDA Avg | $31M | $33M | $34M | $32M | $33M | $35M | $36M |
| Low | $31M | $32M | $34M | $31M | $33M | $34M | $35M |
| High | $32M | $33M | $35M | $32M | $34M | $35M | $36M |
| EBIT Avg | $29M | $30M | $31M | $29M | $31M | $32M | $33M |
| Low | $29M | $30M | $31M | $29M | $31M | $32M | $33M |
| High | $29M | $31M | $32M | $30M | $31M | $33M | $34M |
| Net Income Avg | $32M | $34M | $37M | $33M | $35M | $38M | $40M |
| Low | $30M | $34M | $36M | $32M | $34M | $37M | $39M |
| High | $33M | $35M | $37M | $33M | $36M | $39M | $41M |
| EPS Avg | $1.91 | $2.06 | $2.21 | $1.95 | $2.10 | $2.27 | $2.38 |
| Low | $1.78 | $2.01 | $2.17 | $1.92 | $2.06 | $2.23 | $2.34 |
| High | $1.98 | $2.10 | $2.25 | $1.99 | $2.14 | $2.31 | $2.43 |
| Analysts (Rev / EPS) | 2 / 4 | 2 / 4 | 1 / 2 | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 2 |